Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Phreesia, Inc. (PHR : NYSE)
 
 • Company Description   
Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York.

Number of Employees: 2,082

 
 • Price / Volume Information   
Yesterday's Closing Price: $28.99 Daily Weekly Monthly
20 Day Moving Average: 603,075 shares
Shares Outstanding: 59.50 (millions)
Market Capitalization: $1,725.03 (millions)
Beta: 0.72
52 Week High: $30.53
52 Week Low: $17.07
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 8.13% 3.33%
12 Week 20.49% 2.91%
Year To Date 15.22% 7.92%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
1521 Concord Pike Suite 301 PMB 221
-
Wilmington,DE 19803
USA		 ph: 888-654-7473
fax: 646-607-1776		 investors@phreesia.com http://www.phreesia.com
 
 • General Corporate Information   
Officers
Chaim Indig - Chief Executive Officer
Michael Weintraub - Chairman
Balaji Gandhi - Chief Financial Officer
Yvonne Hui - Vice President
Edward Cahill - Director

Peer Information
Phreesia, Inc. (HLIS)
Phreesia, Inc. (AZTA)
Phreesia, Inc. (APYI)
Phreesia, Inc. (RNVA)
Phreesia, Inc. (HMSY)
Phreesia, Inc. (LRSI)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MEDICAL INFO SYS
Sector: Medical
CUSIP: 71944F106
SIC: 7389
Fiscal Year
Fiscal Year End: January
Last Reported Quarter: 04/01/25
Next Expected EPS Date: 09/03/25
Share - Related Items
Shares Outstanding: 59.50
Most Recent Split Date: (:1)
Beta: 0.72
Market Capitalization: $1,725.03 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.07 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.17 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 09/03/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 6.11
Price/Cash Flow: -
Price / Sales: 3.97
EPS Growth
vs. Year Ago Period: 80.00%
vs. Previous Quarter: 36.36%
Sales Growth
vs. Year Ago Period: 14.54%
vs. Previous Quarter: 5.70%
ROE
04/30/25 - -16.23
01/31/25 - -22.87
10/31/24 - -32.78
ROA
04/30/25 - -11.19
01/31/25 - -15.62
10/31/24 - -22.37
Current Ratio
04/30/25 - 1.95
01/31/25 - 1.78
10/31/24 - 1.74
Quick Ratio
04/30/25 - 1.95
01/31/25 - 1.78
10/31/24 - 1.74
Operating Margin
04/30/25 - -9.83
01/31/25 - -13.94
10/31/24 - -20.43
Net Margin
04/30/25 - -9.83
01/31/25 - -13.94
10/31/24 - -20.43
Pre-Tax Margin
04/30/25 - -9.15
01/31/25 - -13.29
10/31/24 - -19.96
Book Value
04/30/25 - 4.74
01/31/25 - 4.56
10/31/24 - 4.38
Inventory Turnover
04/30/25 - -
01/31/25 - -
10/31/24 - -
Debt-to-Equity
04/30/25 - 0.02
01/31/25 - 0.03
10/31/24 - 0.04
Debt-to-Capital
04/30/25 - 2.14
01/31/25 - 2.99
10/31/24 - 3.89
 

Powered by Zacks Investment Research ©